Page last updated: 2024-09-02

n(g)-iminoethylornithine and Apoplexy

n(g)-iminoethylornithine has been researched along with Apoplexy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carmichael, ST; Doroudchi, MM; Gleichman, AJ; Hinman, JD; Llorente, IL; Ng, KL; Nunez, S; Sozmen, EG1
Ay, H; Dalkara, T; Kirazli, S; Kocaefe, C; Moskowitz, MA; Ozcebe, O; Ozgüç, M; Qui, J; Topalkara, K; Yemisci, M1

Trials

1 trial(s) available for n(g)-iminoethylornithine and Apoplexy

ArticleYear
Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.
    Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 26, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Arginine; Bleeding Time; Blood Platelets; Brain Ischemia; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Ornithine; Platelet Aggregation; Pravastatin; RNA, Messenger; Stroke; Treatment Outcome

2008

Other Studies

1 other study(ies) available for n(g)-iminoethylornithine and Apoplexy

ArticleYear
A Versatile Murine Model of Subcortical White Matter Stroke for the Study of Axonal Degeneration and White Matter Neurobiology.
    Journal of visualized experiments : JoVE, 2016, Mar-17, Issue:109

    Topics: Animals; Axons; Disease Models, Animal; Enzyme Inhibitors; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Nitric Oxide Synthase Type III; Ornithine; Stroke; White Matter

2016